91740 ⎘
Quinones containing halogen
COMPOUNDS AND METHODS FOR THE TREATMENT OF PARASITIC INFECTIONS
#2PROCESS FOR PREPARING TAPINAROF
#3Process for preparing tapinarof
#4METHODS FOR CONVERTING THC-RICH CANNABINOID MIXTURES INTO CBN-RICH CANNABINOID MIXTURES
#5COMPOUNDS AND METHODS FOR THE TREATMENT OF PARASITIC INFECTIONS
#6Methods for converting THC-rich cannabinoid mixtures into CBN-rich cannabinoid mixtures
#7Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
#8Process for preparing tapinarof
#9Process for preparing tapinarof
#10Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
#11Process for preparing tapinarof
#12Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
#13Quantitative intramolecular fission in oligoacenes, materials, and methods of use thereof
#14Tocopherol and tocopheryl quinone derivatives as correctors of lysosomal storage disorders
#15Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
#16Tocopherol and tocopheryl quinone derivatives as correctors of Lysosomal Storage Disorders
#17Methionine Aminopeptidase Inhibitors for Treating Infectious Diseases
#18Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents
#19PROCESS FOR THE EPIMERIZATION OF ATOVAQUONE ISOMER, ATOVAQUONE INTERMEDIATES AND MIXTURE THEREOF
#201,4-naphthoquinones derivatives and therapeutic use thereof
#21Preparation of naphthoquinone compounds using 2,3-dihalonaphthoquinone
#22Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
#23Process for preparation of atovaquone and novel intermediates thereof
#24Heteroacene derivative, tetrahaloterphenyl derivative, and processes for producing the same
#25Non-Peptidic Inhibitors of AKAP/PKA Interaction
#26Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
#27UBIQUINONE ANALOGS AND METHODS OF USE
#28New Drug Delivery System for Crossing the Blood Brain Barrier
#29Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
#30Process for preparing pentacene derivatives
#31Process for conversion of phenol to hydroquinone and quinones